SEC 13F Intelligence

Venrock Adviser, LLC / COGT

Venrock Adviser, LLC’s Cogent Biosciences Inc Position

Does Venrock Adviser, LLC own Cogent Biosciences Inc (COGT)? Yes — 2.00M shares worth $77M (+2.87% of its 13F portfolio) as of Q1 2026.

Position Value
$77M
Q1 2026
Shares
2.00M
% of Portfolio
+2.87%
Quarters Held
22
currently held

Position History COGT

Reported value by quarter
Q4 ’20: $12MQ4 ’20Q1 ’21: $10MQ2 ’21: $9MQ3 ’21: $9MQ3 ’21Q4 ’21: $9MQ1 ’22: $8MQ2 ’22: $36MQ2 ’22Q3 ’22: $60MQ4 ’22: $47MQ1 ’23: $53MQ1 ’23Q2 ’23: $55MQ3 ’23: $46MQ4 ’23: $28MQ4 ’23Q1 ’24: $34MQ2 ’24: $48MQ3 ’24: $61MQ3 ’24Q4 ’24: $44MQ1 ’25: $34MQ2 ’25: $34MQ2 ’25Q3 ’25: $57MQ4 ’25: $71MQ1 ’26: $77MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.00M$77M+2.87%
Q4 20252.00M$71M+3.51%
Q3 20254.00M$57M+3.23%
Q2 20254.76M$34M+2.56%
Q1 20255.68M$34M+2.90%
Q4 20245.68M$44M+3.04%
Q3 20245.68M$61M+3.22%
Q2 20245.68M$48M+3.05%
Q1 20245.13M$34M+1.64%
Q4 20234.68M$28M+1.89%
Q3 20234.68M$46M+4.81%
Q2 20234.68M$55M+8.87%
Q1 20234.88M$53M+10.29%
Q4 20224.04M$47M+7.49%
Q3 20224.04M$60M+8.85%
Q2 20224.04M$36M+6.57%
Q1 20221.09M$8M+1.32%
Q4 20211.09M$9M+1.28%
Q3 20211.09M$9M+1.18%
Q2 20211.09M$9M+1.07%
Q1 20211.09M$10M+1.04%
Q4 20201.09M$12M+1.80%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of COGT.